19 August 2021

Organized so far by PhD candidates and postdoctoral researchers at IRB Barcelona, RIMLS, CPR and SEMM, the ENABLE conferences will be funded by FEBS (Federation of European Biochemical Societies) and IUBMB (International Union of Biochemistry and Molecular Biology), which guarantee the continuity of future gatherings. The 2022, 2023 and 2025 conferences will be held in Europe while the 2024 event will be held outside Europe.

The ENABLE international conferences, which have been held annually since 2017, are scientific gatherings organized by and for young researchers that seek to ensure the next generation of scientific leaders.

Initially funded by the European Commission's Horizon2020 program, the first four conferences were held in the cities hosting the headquarters of the four entities leading the project: the Institute for Research in Biomedicine (IRB Barcelona) in Barcelona, Spain; the Radboud Institute for Molecular Life Sciences  (RIMLS) in Nijmegen, The Netherlands; The Novo Nordisk Foundation Center for Protein Research  (CPR) in Copenhagen, Denmark; and the  Scuola Europea di Medicina Molecolare  (SEMM), in Milan, Italy.

For the next four FEBS-IUBMB-ENABLE events (2022-2025), the Federation of European Biochemical Societies (FEBS) and the International Union of Biochemistry and Molecular Biology (IUBMB), which have sponsored the conferences since 2017, have signed an agreement by which they will fund the organization of the gatherings, thus guaranteeing their continuity.

"ENABLE conferences are a unique opportunity to experience science in a different way. By combining top-notch scientific discussions with career development and public outreach activities, ENABLE empowers young researchers to become the biomedical professionals of tomorrow, " says Gianmarco Di Mauro, organizer of the 1st ENABLE conference (Barcelona 2017).

Learn more about the ENABLE conferences

Associated research centers and intercontinental rotation

In this new cycle of FEBS-IUBMB-ENABLE conferences, in addition to the four core research centers, other international research institutions can apply to become associated centers and host one of the events. Regarding the associated centers, FEBS-IUBMB-ENABLE will look for one in a non-European country to ensure that one of the conferences is held on another continent.

ENABLE (now FEBS-IUBMB-ENABLE) conferences are international and interdisciplinary meetings involving audiences from a variety of backgrounds, cultures and generations. The incorporation of associated research centers allows further enrichment of the FEBS-IUBMB-ENABLE conference programs and provides greater added value, both for the PhD candidates participating in the Organizing Committee and those attending the events.

The essence of FEBS-IUBMB-ENABLE conferences

The FEBS-IUBMB-ENABLE conferences are organized by a Scientific Committee composed of young researchers (PhDs and postdocs) from several European institutions and members from FEBS and the IUBMB Young Scientists Forum (YSF).

The annual ENABLE conference includes a scientific symposium, addressing current issues in molecular life sciences, and a series of activities focused on providing guidance on employment opportunities. FEBS-IUBMB-ENABLE also seeks to engage the general public through outreach events.



  • Want to know more about these subjects? Click on the buttons below for more news.


Related news items

How much should we exercise to live healthier lives? Research into the relationship between exercise, heart disease and mortality

3 December 2021

It has long been known that exercise reduces the risk of many chronic diseases. However, we do not yet know exactly how much exercise is necessary to achieve health benefit.

read more

KNAW Early Career Award for Martine Hoogman

2 December 2021

Martine Hoogman has been awarded a KNAW Early Career Award. The prize, a sum of 15,000 euros and a work of art, is aimed at researchers in the Netherlands who are at the start of their careers and have innovative, original research ideas.

read more

T-Guard can reset immune system

1 December 2021

For 20 years, the Nijmegen based Radboudumc spin-off company Xenikos has been working on a drug that can reset the immune system. This reset will save lives of seriously ill patients. Now, after years of hard work, the moment of truth has arrived for T-guard.

read more

Thomas van den Heuvel wins Stairway to Impact Award for safer pregnancies using AI Award for safer pregnancies using AI

1 December 2021

Radboudumc researcher Thomas van den Heuvel receives the Stairway to Impact Award from Dutch Research Council NWO. He receives this prize for the development of the BabyChecker, a smartphone application that allows midwives to make ultrasounds during pregnancies.

read more

Villa Joep Research Grant for Radiotherapy & OncoImmunology (ROI) lab

1 December 2021

Renske van den Bijgaart and Gosse Adema from the Radiotherapy & OncoImmunology laboratorium in collaboration with the Prinses Maxima Center received a grant from Villa Joep of 410k Euro.

read more

Participating in cancer research among people with intellectual disabilities

30 November 2021

Thanks to the support of the Maarten van der Weijden Foundation research was carried out into the participation of people with intellectual disabilities in (population) screening for cancer.

read more